MD Anderson’s moon shots mission grows to confront six more cancer types
MD Anderson News Release 10/29/2015
MD Anderson’s Moon Shots Program, an unprecedented effort and novel organizational model designed to more rapidly convert scientific discoveries into life-saving advances, has expanded its targets, adding several of the most intractable cancers to its campaign.
The innovative program’s transdisciplinary team-science approach now applies to
B-cell lymphoma, glioblastoma (brain cancer...
‘Reversible’ tumor suppressor loss: key to new brain cancer therapies?
MD Anderson study shows why protein PTEN causes tumor growth in brain but not in other organs
MD Anderson News Release 10/19/15
For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy
Findings encourage practice change for lung cancer management
MD Anderson Cancer Center 10/18/2015
An analysis of...
Study reveals why cancer anemia treatment leads to tumor growth
EphB4 receptor identified as “trigger” for breast and ovarian tumor stimulation
MD Anderson News Release 10/15/2015
Scientists have shown why a drug widely used to treat chemotherapy-induced anemia in ovarian and breast cancer patients also may shorten survival times in some patients by inadvertently stimulating tumor growth.
Anil Sood, M.D., professor of Gynecologic Oncology and Reproductive Medicine at The University...
MD Anderson to honor Houston Texans founder Bob McNair
Trailblazer takes center stage with Tom Brokaw at A Conversation With a Living Legend®
MD Anderson News Release 10/14/15
...
‘Until 20’ Shares Courageous Story, Challenges All to Lead a Giving Life
MD Anderson News Release 10/14/2015
Like the film itself, the world premiere of “Until 20” at the Austin Film Festival will be a celebration...
MD Anderson Cancer Center Board of Visitors welcomes 14 new members
Business and community leaders are committed to advance institution’s efforts to end cancer
MD Anderson News Release 10/09/2015
MD Anderson, Theraclone Sciences form OncoResponse
MD Anderson News Release 10/06/2015
OncoResponse, an immuno-oncology antibody discovery company, has been launched jointly by The...
MD Anderson’s Allison wins American Cancer Society medal of honor
MD Anderson News Release 10/01/2015
A career-long fascination with discovering the ins and outs of T cells, our immune system’...
Study shows new ‘driver’ to assess cancer patient survival and drug sensitivity
RNA editing events another way to investigate biomarkers and therapy targets
MD Anderson News Release 10/01/2015